AHA GUIDELINES Bundle (free trial)

Stable Ischemic Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/102913

Contents of this Issue

Navigation

Page 30 of 45

29 Alternative Therapies for Relief of Symptoms in Patients with Refractory Angina Î Enhanced external counterpulsation (EECP) may be considered for relief of refractory angina in patients with SIHD. (IIb–B) Î Spinal cord stimulation may be considered for relief of refractory angina in patients with SIHD. (IIb-C: No Benefit) Î Transmyocardial revascularization (TMR) may be considered for relief of refractory angina in patients with SIHD. (IIb-B) Î Acupuncture should not be used for the purpose of improving symptoms or reducing cardiovascular risk in patients with SIHD. (III-C: No Benefit) Additional Therapy to Reduce Risk of MI And Death Î NOT recommended with the intent of reducing cardiovascular risk or improving clinical outcomes: No Benefit • Estrogen therapy (III-A) • Vitamin C, vitamin E, and beta-carotene supplementation. (III-A) • Treatment of elevated homocysteine with folate or vitamins B6 and B12 (III-A) • Chelation therapy (III-C) • Garlic, coenzyme Q10, selenium, and chromium (III-C) Revascularization Î A Heart Team approach to revascularization is recommended in patients with unprotected left main or complex CAD. (I-C) Î Calculation of the STS (http://riskcalc.sts.org/STSWebRiskCalc273/ de.aspx) and SYNTAX (http://www.syntaxscore.com/calc/start.htm) scores is reasonable in patients with unprotected left main and complex CAD. (IIa-B)

Articles in this issue

Links on this page

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Stable Ischemic Heart Disease